138 related articles for article (PubMed ID: 9176043)
1. Effects of ordinary meals on plasma concentrations of 3,4-dihydroxyphenylalanine, dopamine sulphate and 3,4-dihydroxyphenylacetic acid.
Eldrup E; Møller SE; Andreasen J; Christensen NJ
Clin Sci (Lond); 1997 Apr; 92(4):423-30. PubMed ID: 9176043
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
Eldrup E; Clausen N; Scherling B; Schmiegelow K
Scand J Clin Lab Invest; 2001; 61(6):479-90. PubMed ID: 11681538
[TBL] [Abstract][Full Text] [Related]
3. CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.
Eldrup E; Mogensen P; Jacobsen J; Pakkenberg H; Christensen NJ
Acta Neurol Scand; 1995 Aug; 92(2):116-21. PubMed ID: 7484057
[TBL] [Abstract][Full Text] [Related]
4. DOPA, dopamine, and DOPAC concentrations in the rat gastrointestinal tract decrease during fasting.
Eldrup E; Richter EA
Am J Physiol Endocrinol Metab; 2000 Oct; 279(4):E815-22. PubMed ID: 11001763
[TBL] [Abstract][Full Text] [Related]
5. Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats.
Kvetnanský R; Goldstein DS; Weise VK; Holmes C; Szemeredi K; Bagdy G; Kopin IJ
J Neurochem; 1992 Jun; 58(6):2296-302. PubMed ID: 1573408
[TBL] [Abstract][Full Text] [Related]
6. Increase in plasma 3,4-dihydroxyphenylalanine (DOPA) appearance rate after inhibition of DOPA decarboxylase in humans.
Eldrup E; Hetland ML; Christensen NJ
Eur J Clin Invest; 1994 Mar; 24(3):205-11. PubMed ID: 8033956
[TBL] [Abstract][Full Text] [Related]
7. The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA and neuropeptide Y-like immunoreactivity in normal human subjects.
Hetland ML; Eldrup E; Bratholm P; Christensen NJ
Scand J Clin Lab Invest; 1991 May; 51(3):219-24. PubMed ID: 1909048
[TBL] [Abstract][Full Text] [Related]
8. Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable.
Shigetomi S; Kuchel O
Am J Hypertens; 1993 Jan; 6(1):33-40. PubMed ID: 8427659
[TBL] [Abstract][Full Text] [Related]
9. High sodium intake increases the urinary excretion of L-3,4-dihydroxyphenylalanine but fails to alter the urinary excretion of dopamine and amine metabolites in Wistar rats.
Vieira-Coelho MA; Pestana M; Soares-da-Silva P
Gen Pharmacol; 1996 Dec; 27(8):1421-7. PubMed ID: 9304419
[TBL] [Abstract][Full Text] [Related]
10. Method for the determination of gamma-L-glutamyl-L-dihydroxyphenylalanine and its major metabolites L-dihydroxyphenylalanine, dopamine and 3,4-dihydroxyphenylacetic acid by high-performance liquid chromatography with electrochemical detection.
Cummings J; Matheson LM; Smyth JF
J Chromatogr; 1990 Jun; 528(1):43-53. PubMed ID: 2117019
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
Andersen AD; Blaabjerg M; Binzer M; Kamal A; Thagesen H; Kjaer TW; Stenager E; Gramsbergen JBP
J Neurochem; 2017 May; 141(4):614-625. PubMed ID: 28244186
[TBL] [Abstract][Full Text] [Related]
12. Plasma sulfoconjugated dopamine levels are normal in patients with autonomic failure.
Yamamoto T; Polinsky RJ; Goldstein DS; Baucom CE; Kopin IJ
J Lab Clin Med; 1996 Nov; 128(5):488-91. PubMed ID: 8900291
[TBL] [Abstract][Full Text] [Related]
13. Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection.
Holmes C; Eisenhofer G; Goldstein DS
J Chromatogr B Biomed Appl; 1994 Mar; 653(2):131-8. PubMed ID: 8205240
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous measurement of DOPA, DOPAC, and catecholamines in plasma by liquid chromatography with electrochemical detection.
Goldstein DS; Stull R; Zimlichman R; Levinson PD; Smith H; Keiser HR
Clin Chem; 1984 May; 30(5):815-6. PubMed ID: 6424968
[No Abstract] [Full Text] [Related]
15. Rapid procedure for chromatographic isolation of DOPA, DOPAC, epinephrine, norepinephrine and dopamine from a single urinary sample at endogenous levels.
Dalmaz Y; Peyrin L
J Chromatogr; 1978 Jan; 145(1):11-27. PubMed ID: 621235
[TBL] [Abstract][Full Text] [Related]
16. Determination of picomole amounts of dopamine, noradrenaline, 3,4-dihydroxyphenylalanine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindolacetic acid in nervous tissue after one-step purification on Sephadex G-10, using high-performance liquid chromatography with a novel type of electrochemical detection.
Westerink BH; Mulder TB
J Neurochem; 1981 Apr; 36(4):1449-62. PubMed ID: 6167673
[TBL] [Abstract][Full Text] [Related]
17. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
Huang L; Deng M; Zhang S; Fang Y; Li L
Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
[TBL] [Abstract][Full Text] [Related]
18. Significance and origin of DOPA, DOPAC, and dopamine-sulphate in plasma, tissues and cerebrospinal fluid.
Eldrup E
Dan Med Bull; 2004 Feb; 51(1):34-62. PubMed ID: 16009071
[No Abstract] [Full Text] [Related]
19. Effects of tyrosine and tryptophan ingestion on plasma catecholamine and 3,4-dihydroxyphenylacetic acid concentrations.
Rasmussen DD; Ishizuka B; Quigley ME; Yen SS
J Clin Endocrinol Metab; 1983 Oct; 57(4):760-3. PubMed ID: 6885965
[TBL] [Abstract][Full Text] [Related]
20. Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson's disease and during ageing in non-Parkinsonian subjects.
Fornstedt Wallin B
J Neural Transm (Vienna); 2024 Mar; 131(3):213-228. PubMed ID: 38238531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
